Skip to main content
. 2020 Mar 30;20:414. doi: 10.1186/s12889-020-08553-4

Table 2.

Summary of knowledge of cancer age-related risk and its prevalence in Gaza

Question Total
(n = 2886)
n (%)
Adolescents
(n = 1457)
n (%)
Adults
(n = 1429)
n (%)
p value Females
(n = 1483)
n (%)
Males
(n = 1403)
n (%)
p value

In the next year, who is most likely to develop cancer?

Someone in their:

 20’s 260 (9.0) 104 (7.1) 156 (10.9) < 0.001 132 (8.9) 128 (9.1) < 0.001
 30’s 175 (6.1) 54 (3.7) 121 (8.5) 88 (5.9) 87 (6.2)
 40’s 183 (6.3) 64 (4.4) 119 (8.3) 82 (5.5) 101 (7.2)
 50’s 115 (4.0) 39 (2.7) 76 (5.3) 49 (3.3) 66 (4.7)
 60’s 94 (3.3) 31 (2.1) 63 (4.4) 33 (2.2) 61 (4.3)
 70’s 27 (0.9) 9 (0.6) 18 (1.3) 10 (0.7) 17 (1.2)
 80’s 35 (1.2) 6 (0.4) 29 (2.0) 13 (0.9) 22 (1.6)
 Cancer is unrelated to age 1885 (65.3) 1047 (71.9) 838 (58.7) 1063 (71.7) 822 (58.6)
 I do not know 112 (3.9) 103 (7.1) 9 (0.6) 13 (0.9) 99 (7.1)
What do you think is the most common cancer in women?
 Breast cancer 2220 (76.9) 981 (67.3) 1239 (86.7) < 0.001 1116 (75.3) 1104 (78.7) 0.010
 Uterine cancer 63 (2.2) 29 (2.0) 34 (2.4) 30 (2.0) 33 (2.4)
 Cervical cancer 23 (0.8) 15 (1.0) 8 (0.6) 9 (0.6) 14 (1.0)
 Leukemia 21 (0.7) 8 (0.5) 13 (0.9) 6 (0.4) 15 (1.1)
 Colon cancer 11 (0.4) 2 (0.1) 9 (0.6) 6 (0.4) 5 (0.4)
 Others 37 (1.3) 16 (1.2) 21 (1.5) 15 (0.9) 22 (1.4)
 I do not know 511 (17.7) 406 (27.9) 105 (7.3) 301 (20.3) 210 (15.0)
What do you think is the most common cancer in men?
 Lung cancer 620 (21.5) 244 (16.7) 376 (26.3) < 0.001 284 (19.2) 336 (23.9) < 0.001
 Prostate cancer 627 (21.7) 241 (16.5) 386 (27.0) 322 (21.7) 305 (21.7)
 Leukemia 245 (8.5) 110 (7.5) 135 (9.4) 108 (7.3) 137 (9.8)
 Brain cancer 90 (3.1) 50 (3.4) 40 (2.8) 49 (3.3) 41 (2.9)
 Colon cancer 196 (6.8) 33 (2.3) 163 (11.4) 80 (5.4) 116 (8.3)
 Liver cancer 74 (2.6) 48 (3.3) 26 (1.8) 34 (2.3) 40 (2.9)
 Testicular cancer 46 (1.6) 32 (2.2) 14 (1.0) 26 (1.8) 20 (1.4)
 Others 214 (7.4) 148 (10.3) 66 (4.7) 100 (6.7) 114 (8.1)
 I do not know 774 (26.8) 551 (37.8) 223 (15.6) 480 (32.3) 294 (21.0)

n number of participants tested